Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
Canadian Medical Association Journal|June 21, 1975
Letter: cH OR PHP Seeman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1992
Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4P Seeman
Biochemical Pharmacology|October 1, 1977
Anti-schizophrenic drugs--membrane receptor sites of actionP Seeman
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkageP Seeman
Translational Psychiatry|October 19, 2016
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical doseP Seeman
Canadian Journal of Physiology and Pharmacology|March 1, 1973
Macromolecules may inhibit diffusion of hemoglobin from lysing erythrocytes by exclusion of solventP Seeman
Canadian Medical Association Journal|October 5, 1974
Medical research policy for Canada. Potential dialogue between MD and MPP Seeman
Biochemical Pharmacology|August 15, 1982
Nomenclature of central and peripheral dopaminergic sites and receptorsP Seeman
International Clinical Psychopharmacology|September 1, 1995
Therapeutic receptor-blocking concentrations of neurolepticsP Seeman
Lancet (London, England)|May 16, 1981
Dopamine receptors in post-mortem schizophrenic brainsP Seeman
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Canadian Medical Association Journal|June 21, 1975
Letter: cH OR PHP Seeman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1992
Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4P Seeman
Biochemical Pharmacology|October 1, 1977
Anti-schizophrenic drugs--membrane receptor sites of actionP Seeman
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkageP Seeman
Translational Psychiatry|October 19, 2016
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical doseP Seeman
Canadian Journal of Physiology and Pharmacology|March 1, 1973
Macromolecules may inhibit diffusion of hemoglobin from lysing erythrocytes by exclusion of solventP Seeman
Canadian Medical Association Journal|October 5, 1974
Medical research policy for Canada. Potential dialogue between MD and MPP Seeman
Biochemical Pharmacology|August 15, 1982
Nomenclature of central and peripheral dopaminergic sites and receptorsP Seeman
International Clinical Psychopharmacology|September 1, 1995
Therapeutic receptor-blocking concentrations of neurolepticsP Seeman
Lancet (London, England)|May 16, 1981
Dopamine receptors in post-mortem schizophrenic brainsP Seeman
Pageof 33